Trupanion Reports Second Quarter 2014 Results - 19 Action News|Cleveland, OH|News, Weather, Sports

Trupanion Reports Second Quarter 2014 Results

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Trupanion, Inc.

SEATTLE, Aug. 27, 2014 /PRNewswire/ -- Trupanion, Inc. (NYSE:TRUP), a direct-to-consumer, monthly subscription business that provides medical plans to cats and dogs, today announced financial results for the second quarter of 2014.

Trupanion Logo.

"We had a solid second quarter; and yet, we have significant runway ahead of us because we are operating in what we believe is a massive, underpenetrated market," said Darryl Rawlings, CEO of Trupanion. "Our goal is to become the category leader in this market. Propelled by a superior product and a powerful, veterinarian-focused sales strategy, we believe we are well positioned to take advantage of this opportunity and assume a leading role in building the category."

Second Quarter 2014 Financial Highlights

  • Total revenue for the second quarter of 2014 was $28.1 million, an increase of 42% from the second quarter of 2013.
  • Subscription business revenue for the second quarter of 2014 was $25.4 million, an increase of 38% from the second quarter of 2013.
  • Net Loss for the second quarter of 2014 was $3.5 million, compared to a net loss of $1.8 million for the second quarter of 2013. Adjusted EBITDA loss for the second quarter of 2014 was $2.5 million, compared to an adjusted EBITDA loss of $1.0 million for the second quarter of 2013. This loss is attributable primarily to spending related to continued expansion of Trupanion Express, public company preparedness, and a non-recurring severance charge. During the second quarter of 2014 we continued to invest in Trupanion Express, a software solution for veterinarians that enables direct-to-veterinarian claims payments and more efficient claims handling. We anticipate continuing to invest in initiatives such as Trupanion Express for the foreseeable future.
  • As of June 30, 2014, Trupanion had $29.6 million in outstanding debt, which decreased to $14.9 million in July 2014.

Operating Metrics

  • Total enrolled pets for the second quarter of 2014 was 194,617, an increase of 32% from the second quarter of 2013.
  • Average monthly adjusted revenue per pet for the second quarter of 2014 was $43.90, an increase of 4% from the second quarter of 2013.
  • The ratio of lifetime value of a pet (LVP) to average pet acquisition cost (PAC) or LVP:PAC ratio was 5.4 to 1.

Business Highlights

In July 2014, Trupanion sold 8,193,750 shares of common stock at a price of $10.00 per share in its initial public offering. The net proceeds, after deducting underwriting discounts and commissions and offering expenses, were approximately $73 million.

Business Outlook

  • Total revenue is expected to be between $29 million and $30.2 million for the third quarter of 2014.
  • Adjusted EBITDA is expected to be between $(4.3) million and $(3.1) million for the third quarter of 2014.
  • Total revenue is expected to be between $114 million and $116 million for the full year 2014.
  • Adjusted EBITDA is expected to be between $(11.8) million and $(9.8) million for the full year 2014.

Conference Call

Trupanion's management will host a conference call today to review its second quarter 2014 results and to discuss its financial outlook for the third quarter and full year 2014. The call is scheduled to begin at 2:00 p.m. PT/5:00 p.m. ET. A live webcast will be accessible through the Investor Relations section of Trupanion's website at Trupanion.com and will be archived online for 60 days upon completion of the conference call. Participants can access the conference call by dialing 1-888-317-6016 (United States), 1-855-669-9657 (Canada), or 1-412-317-6016 (international). A telephonic replay of the call will also be available, one hour after the completion of the call, by dialing 1-877-344-7529 (United States), 1-855-669-9658 (Canada), or 1-412-317-0088 (international) and entering the replay pin number: 10051103.

About Trupanion

Trupanion is a leading direct-to-consumer, monthly subscription business that provides medical plans to cats and dogs in the United States, Canada and Puerto Rico. As of June 30, 2014, Trupanion provided medical coverage to over 194,000 pets. The company is headquartered in Seattle, WA and can be found online at Trupanion.com. Trupanion's shares are traded on the New York Stock Exchange under the ticker symbol TRUP.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 relating to, among other things, expectations, plans, prospects and financial results for Trupanion, including, but not limited to, its expectations regarding future operating results and expenditures. These forward-looking statements are based upon the current expectations and beliefs of Trupanion's management as of the date of this press release, and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. All forward-looking statements made in this press release are based on information available to Trupanion as of the date hereof, and Trupanion has no obligation to update these forward-looking statements.

In particular, the following factors, among others, could cause results to differ materially from those expressed or implied by such forward-looking statements: the ability to achieve or maintain profitability in the future; the accuracy of assumptions used in determining appropriate member acquisition expenditures; the ability to maintain high retention rates; the accuracy of assumptions used in pricing medical plan subscriptions; actual claims expense not exceeding reserves; the effectiveness of Territory Partners, veterinarians and other third parties in recommending medical plan subscriptions to potential members; the ability to maintain the requisite amount of risk-based capital; the ability to recognize benefits from investments in new solutions and enhancements to our technology platform; and compliance with laws and regulations that apply to sale of a pet medical plan. 

For a detailed discussion of these and other cautionary statements, please refer to the risk factors discussed in filings with the  Securities and Exchange Commission (SEC), including but not limited to Trupanion's Prospectus filed with the SEC pursuant to Rule 424(b)(4) on July 18, 2014 and any subsequently filed reports on Forms 10-Q and 8-K. All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval system at www.sec.gov or the investor relation section of Trupanion's website at http://investors.trupanion.com.

Non-GAAP Financial Measures

Trupanion's stated results include certain non-GAAP financial measures, including adjusted revenue, contribution margin, acquisition cost and adjusted EBITDA, and non-GAAP expenses (General & Administrative, Sales & Marketing and Technology). Monthly adjusted revenue per pet is calculated in part based on adjusted revenue, a non-GAAP financial measure, that Trupanion defines as revenue from our subscription business segment excluding sign-up fee revenue and the change in deferred revenue between periods. Lifetime value of a pet is calculated in part based on contribution margin, a non-GAAP financial measure, that Trupanion defines as gross profit from our subscription business segment for the 12 months prior to the period end date excluding stock-based compensation expense related to cost of revenue from our subscription business segment, sign-up fee revenue and the change in deferred revenue between periods. Average pet acquisition cost is calculated in part based on acquisition cost, a non-GAAP financial measure ,that Trupanion defines as sales and marketing expenses, excluding stock-based compensation expense, net of sign-up fee revenue. Adjusted EBITDA is a non-GAAP financial measure that Trupanion defines as net loss excluding stock-based compensation expense, depreciation and amortization expense, interest income, interest expense, change in fair value of warrant liabilities and income tax expense (benefit).

Trupanion's non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in its industry as other companies in its industry may calculate or use non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies and exclude expenses that may have a material impact on its reported financial results. Further, stock-based compensation expense and other items used in the calculation of adjusted EBITDA have been and will continue to be for the foreseeable future significant recurring expenses in Trupanion's business. The presentation and utilization of non-GAAP financial measures is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP. Trupanion urges its investors to review the reconciliation of its non-GAAP financial measures to the most directly comparable GAAP financial measures in its consolidated financial statements, and not to rely on any single financial or operating measure to evaluate its business.

Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company's non-cash expenses, Trupanion believes that providing non-GAAP financial measures such as contribution margin, acquisition cost and adjusted EBITDA that exclude stock-based compensation expense and, in the case of adjusted EBITDA, the change in fair value of warrant liabilities allows for more meaningful comparisons between its operating results from period to period. Trupanion excludes sign-up fee revenue from the calculation of both adjusted revenue and contribution margin because it collects sign-up fee revenue from new members at the time of enrollment and consider it to be an offset to a portion of Trupanion's sales and marketing expenses. For this reason, Trupanion also nets sign-up fees with sales and marketing expenses in its calculation of acquisition cost. Trupanion excludes changes in deferred revenue from the calculation of both adjusted revenue and contribution margin in order to eliminate fluctuations caused by the timing of pet enrollment during the last month of any particular period in which such measures are being presented or utilized. Trupanion excludes the change in fair value of warrant liabilities from its calculation of adjusted EBITDA in order to eliminate fluctuations caused by changes in its stock price. Trupanion believes this allows it to calculate and present adjusted revenue, contribution margin and acquisition cost and the related financial measures it derives from them, as well as adjusted EBITDA, in a consistent manner across periods. Trupanion's non-GAAP financial measures and the related financial measures it derives from them are important tools for financial and operational decision-making and for evaluating its own operating results over different periods of time.

Trupanion has not reconciled adjusted EBITDA guidance to net income (loss) guidance because it does not provide guidance for stock-based compensation expense, depreciation and amortization, interest income, interest expense, change in fair value of warrant liabilities or income tax expense (benefit), which are reconciling items between net income (loss) and adjusted EBITDA.  As items that impact net income (loss) are out of Trupanion's control and cannot be reasonably predicted, Trupanion is unable to provide such guidance. Accordingly, reconciliation to net income (loss) is not available without unreasonable effort.  For a reconciliation of historical non-GAAP financial measures to the nearest comparable GAAP measures, see the reconciliation tables included in this press release.

Adjusted EBITDA excludes provision for income taxes, interest expense, interest income, amortization of acquired intangible asset, depreciation and other amortization expense, and expenses related to stock-based compensation. Non-GAAP expenses exclude expenses related to stock-based compensation. Adjusted EBITDA excludes these expenses as they are often excluded by other companies to help investors understand the operational performance of their business, and in the case of stock-based compensation, can be difficult to predict. Trupanion believes these adjustments provide useful comparative information to investors.

Trupanion considers these non-GAAP financial measures to be important because they provide useful measures of its operating performance and are used by its management for that purpose. In addition, investors often use measures such as these to evaluate the operating performance of a company. Non-GAAP results are presented for supplemental informational purposes only for understanding Trupanion's operating results. The non-GAAP results should not be considered a substitute for financial information presented in accordance with generally accepted accounting principles, and may be different from non-GAAP measures used by other companies.

Contacts: 

Investor Relations Website:  http://investors.trupanion.com 

Investors: Quynh Pham, Director, Investor Relations
InvestorRelations@trupanion.com
206.607.1940

Media: Britta Gidican, Director, Public Relations
MediaRelations@trupanion.com
206.607.1930

 

Trupanion, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except for share data)















JUNE 30,



DECEMBER 31,



2014



2013



(unaudited)




Assets






Current assets:






Cash and cash equivalents

$

9,288


$

14,939

Investments in fixed maturities, at amortized cost (fair value: $14,071 and $16,088)


14,072



16,088

Accounts and other receivables


8,095



7,771

Prepaid expenses and other assets


1,059



935

Total current assets


32,514



39,733

Restricted cash


2,700



3,000

Investments in fixed maturities, at fair value (amortized cost: $1,000)


927



832

Property and equipment, net


5,167



3,124

Deferred offering costs


2,562



54

Intangible assets, net


4,880



4,910

Total assets

$

48,750


$

51,653

Liabilities, redeemable convertible preferred stock, and stockholders' deficit






Current liabilities:






Accounts payable

$

4,179


$

1,263

Accrued liabilities


4,372



3,660

Claims reserve


4,393



5,612

Deferred revenue


8,771



8,468

Short-term debt


1,200



900

Warrant liabilities


4,380



4,900

Other payables


1,313



1,138

Deferred tax liabilities


82



82

Total current liabilities


28,690



26,023

Long-term debt


24,997



25,199

Deferred tax liabilities


1,542



1,540

Other liabilities


792



166

Total liabilities


56,021



52,928

Contingencies (Note 6)






Redeemable convertible preferred stock: $0.00001 par value per share, 15,666,748 and 15,648,723 authorized at June 30, 2014 and December 31, 2013 and 14,944,945 and 14,857,989 shares issued and outstanding at June 30, 2014 and December 31, 2013.


32,724



31,724

Stockholders' deficit:






Common stock, $0.00001 par value per share, 26,000,000 shares authorized at June 30, 2014 and December 31, 2013 and 2,256,578 shares issued and outstanding at June 30, 2014; 2,236,641 shares issued and outstanding at December 31, 2013.


-



-

Special voting shares, $0.00001 par value per share, 2,500,030 shares authorized at June 30, 2014 and December 31, 2013 and 2,247,130 issued and outstanding at June 30, 2014 and December 31, 2013.


-



-

Additional paid-in capital


7,046



5,769

Accumulated other comprehensive loss


(45)



(164)

Accumulated deficit


(44,395)



(36,003)

Treasury stock, at cost: 620,979 shares at June 30, 2014 and December 31, 2013.


(2,601)



(2,601)

Total stockholders' deficit


(39,995)



(32,999)

Total liabilities, redeemable convertible preferred stock, and stockholders' deficit

$

48,750


$

51,653

 

 

Trupanion, Inc.

Condensed Consolidated Statements of Operations

(in thousands)

(unaudited)
















THREE MONTHS ENDED


SIX MONTHS ENDED



JUNE 30,


JUNE 30,



2014


2013


2014


2013




(in thousands)














Revenue:













Subscription business


$

25,359


$

18,368


$

48,448


$

35,385

Other business



2,731



1,474



5,282



2,299

Total revenue



28,090



19,842



53,730



37,684

Cost of revenue:













Subscription business(1)



20,518



14,698



39,121



28,171

Other business



2,422



1,315



4,703



2,076

Total cost of revenue



22,940



16,013



43,824



30,247

Gross profit:













Subscription business



4,841



3,670



9,327



7,214

Other business



309



159



579



223

Total gross profit



5,150



3,829



9,906



7,437

Operating expenses:













Sales and marketing(1)



2,810



2,268



5,456



4,840

Technology and development(1)



2,553



1,152



4,753



2,035

General and administrative(1)



3,292



2,022



6,078



3,949

Total operating expenses



8,655



5,442



16,287



10,824

Operating loss



(3,505)



(1,613)



(6,381)



(3,387)

Interest expense



726



143



1,468



266

Other (income) expense, net



(759)



73



522



181

Loss before income taxes



(3,472)



(1,829)



(8,371)



(3,834)

Income tax expense (benefit)



7



(5)



21



(84)

Net loss


$

(3,479)


$

(1,824)


$

(8,392)


$

(3,750)



























(1) Includes stock-based compensation expense as follows:




























THREE MONTHS ENDED


SIX MONTHS ENDED



JUNE 30,


JUNE 30,




2014



2013



2014



2013



(in thousands)

Cost of revenue


$

64


$

48


$

145


$

88

Sales and marketing



144



202



293



345

Technology and development



98



94



196



165

General and administrative



320



141



559



288

Total stock-based compensation expense


$

626


$

485


$

1,193


$

886

 

 

Trupanion, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)










SIX MONTHS ENDED 



JUNE 30,




2014



2013

Operating activities







Net loss


$

(8,392)


$

(3,750)

Adjustments to reconcile net loss to cash used in operating activities:







Depreciation and amortization



729



419

Amortization of debt discount



470



8

Loss on disposal of equipment



48



-

Warrant expense



480



126

Stock-based compensation expense



1,193



886

Loss from equity method investment



-



52

Net amortization on bonds



4



11

Changes in operating assets and liabilities:







Accounts receivable



(320)



(4,623)

Prepaid expenses and other current assets



(121)



94

Accounts payable



75



(57)

Accrued liabilities



(428)



(406)

Claims reserve



(1,219)



2,123

Deferred revenue



303



3,423

Other payables



743



10

Net cash used in operating activities



(6,435)



(1,684)

Investing activities







Purchases of investment securities, held-to-maturity



(16,266)



(9,394)

Maturities of investment securities, held-to-maturity



18,277



9,106

Purchases of property and equipment



(2,268)



(877)

Net cash used in investing activities



(257)



(1,165)

Financing activities







Restricted cash



300



-

Advance on term loan



2,000



-

Deferred financing costs



(1,091)



-

Proceeds from exercise of stock options



46



374

(Repayment of) proceeds from line of credit



(300)



3,200

Net cash provided by financing activities



955



3,574

Effect of foreign exchange rates on cash, net



86



110

Net (decrease) increase in cash and cash equivalents



(5,651)



835

Cash and cash equivalents at beginning of period



14,939



4,234

Cash and cash equivalents at end of period


$

9,288


$

5,069

 

 

Trupanion, Inc.

Reconciliation of Non-GAAP Financial Measures to GAAP Measures

(in thousands)

(unaudited)














The following table reflects the reconciliation of adjusted revenue to revenue:
















THREE MONTHS ENDED


SIX MONTHS ENDED



JUNE 30,


JUNE 30,




2014



2013



2014



2013



(in thousands)

Revenue


$

28,090


$

19,842


$

53,730


$

37,684

Excluding:













Other business revenue



(2,731)



(1,474)



(5,282)



(2,299)

Change in deferred revenue



84



218



346



342

Sign-up fee revenue



(407)



(356)



(784)



(688)

Adjusted revenue


$

25,036


$

18,230


$

48,010


$

35,039



























The following table reflects the reconciliation of contribution margin to gross profit:





























THREE MONTHS ENDED









JUNE 30,










2014



2013










(in thousands)







Gross profit


$

18,113


$

14,263







Excluding:













Stock-based compensation expense



287



143







Other business segment gross profit



(1,086)



(267)







Sign-up fee revenue



(1,514)



(1,285)







Change in deferred revenue



1,111



761







Contribution margin


$

16,911


$

13,615














































The following table reflects the reconciliation of acquisition cost to sales and marketing expenses:





























THREE MONTHS ENDED


SIX MONTHS ENDED



JUNE 30,


JUNE 30,




2014



2013



2014



2013



(in thousands)

Sales and marketing expenses


$

2,810


$

2,268


$

5,456


$

4,840

Excluding:













Stock-based compensation expense



(144)



(202)



(293)



(345)

Net of:













Sign-up fee revenue



(407)



(356)



(784)



(688)

Acquisition cost


$

2,259


$

1,710


$

4,379


$

3,807





















































The following table reflects the reconciliation of adjusted EBITDA to net loss:
















THREE MONTHS ENDED


SIX MONTHS ENDED



JUNE 30,


JUNE 30,




2014



2013



2014



2013



(in thousands)

Net loss


$

(3,479)


$

(1,824)


$

(8,392)


$

(3,750)

Excluding:













Stock-based compensation expense



626



485



1,193



886

Depreciation and amortization expense



419



214



729



419

Interest income



(18)



(27)



(36)



(57)

Interest expense



726



143



1,468



266

Change in fair value of warrant liabilities



(740)



28



480



126

Income tax expense (benefit)



7



(5)



22



(84)

Adjusted EBITDA


$

(2,459)


$

(986)


$

(4,536)


$

(2,194)

Logo - http://photos.prnewswire.com/prnh/20140306/SF78009LOGO

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow